BIOMEDIQ A/S: Financial statements 2012
CVR: 31176891
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
BIOMEDIQ A/S (CVR 31176891) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 6,637,825 and a net result of DKK 50,652. The profit margin was 0.8%. Equity in the 2012 report amounted to DKK 410,455. The solvency ratio was 11.3%.
- Revenue
- DKK 6,637,825
- Gross Profit
- DKK 3,452,052
- Profit/Loss
- DKK 50,652
- Equity
- DKK 410,455
- Total Assets
- DKK 3,639,580
Official annual report
Keep an eye on BIOMEDIQ A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout BIOMEDIQ A/S
BIOMEDIQ A/S is a Danish company of the type Aktieselskab based in København K, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SYNARC IMAGING TECHNOLOGY A/S and NORDIC BIOSCIENCE IMAGING A/S. The management consists of Mads Nielsen. The board consists of Pieter Kroese (chair), Mads Nielsen and Martin Lillholm. The company is owned by Screenpoint Medical B.V. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -304,901 and a net result of DKK -977,037 compared with DKK -56,669 the year before. Equity in the 2025 report amounted to DKK -979,433.
